Patents/Assignees

ASGARD THERAPEUTICS AB

1 patent in portfolio

US12600947utility2026
Composition for Reprogramming Cells Into Plasmacytoid Dendritic Cells or Interferon Type I-producing Cells, Methods and Uses Thereof
0 cites